What do you say when giving a talk at a university where you once worked? To speak about publishing, research, and the BMJ would be quite straightforward. It was a […]
Month: October 2012
Julian Sheather: Safeguarding adults—respecting freedom, maximising welfare
I was in Bromley recently at an adult safeguarding conference. It was in some respects a melancholy day. We heard about Brent Martin, a 23 year-old with learning disabilities and […]
Alexander Ferris on helping young people make healthy eating choices
Earlier this year, Old Vic New Voices (OVNV) staged an ambitious new musical called Epidemic, devised and performed by over 400 community volunteers. The piece explored some of the UK’s […]
Richard Smith: Stratified medicine vs the polypill
In the past month I’ve attended contrasting meetings on the polypill and stratified medicine that leave me wondering about the future of medicine. The problem that the polypill tries to […]
David Payne: How websites changed newspapers
The editor emailed me this to seek my views about how to make her weekly Editor’s Choice more relevant to the journal’s online readers. The article gets posted on bmj.com every Wednesday […]
Nathan Ford and Philipp du Cros: Gathering the evidence to improve healthcare in developing countries
A couple of sample dilemmas faced recently in the clinical programmes of the medical humanitarian organisation Médecins Sans Frontières (MSF). “This HIV positive woman in her first trimester of pregnancy […]
Tom Yates: Panorama—Britain’s Secret Health Tourists
In my opinion a recent Panorama programme, “Britain’s Secret Health Tourists,” didn’t do justice to a complex issue. With a Department of Health consultation looming on the issue, it’s important […]
Muir Gray: Defining the scope of systems of care
Read the first in this series of blogs about designing and planning population based systems of care here. Step 1: Defining the scope The focus of a system may be: […]
Richard Smith: Stratified, personalised, or precision medicine
Doctors know that many of the patients they treat with drugs will not benefit. Many patients know that too, which may be why some don’t take their drugs. The simple […]
Richard Lehman’s journal review—15 October 2012
JAMA 10 Oct 2012 Vol 308 1433 A Viewpoint piece by three Dutch radiologists explores the possible added benefits that could arise if developed countries introduced lung cancer screening using […]